Free Newsletter
U.K. proffers €56M for 12 new research units
A dozen new Biomedical Research Units created under the U.K.'s National Institute for Health Research will receive more than €56 million to fund translational work on ailments that include obesity and heart disease. Each of the BRUs match a university with the National Health Service (NHS) Trust. And the public funding is intended to finance work in research areas that are usually starved of funding. Their work is also intended to complement R&D programs at the 12 existing NIHR Biomedical Research Centres.
"Together, these are among the most outstanding centres of medical research in the world," said the Department of Health.
- read the story in PharmaTimes
Related Articles:
Biopharma execs sign on to tout UK's R&D work. U.K. report
Market volatility spurs M&A talks at UK biotechs. M&A report
U.K. to require more disclosure of drug trial data. Drug trial report
U.K. researchers driven out by tough regulations. U.K. report
GSK looks abroad for more scientists as U.K. shortage grows. Report
Comments
Post new comment
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact




